...
首页> 外文期刊>European journal of neurology: the official journal of the European Federation of Neurological Societies >Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries
【24h】

Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries

机译:逆向磁共振血管造影和弥散加权成像不匹配患者的静脉溶栓治疗:SAMURAI和NCVC rt-PA注册

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purpose: The characteristics of reverse magnetic resonance angiography and diffusion-weighted imaging (MRA-DWI) mismatch (RMM), defined as a large DWI lesion in the absence of major artery occlusion (MAO), remain unknown, especially in patients treated with intravenous recombinant tissue plasminogen activator (rt-PA). Methods: Patients with stroke in the middle cerebral artery territory were included. Early ischaemic changes (EIC) were assessed with the Alberta Stroke Program Early CT Score on DWI (DWI-ASPECTS). All patients were divided into four groups based on the presence of MAO and a DWI-ASPECTS cut-off value of <7. RMM was defined as DWI-ASPECTS <7 without MAO. Clinical characteristics, symptomatic intracerebral hemorrhage (sICH) and favorable functional outcome (modified Rankin Scale score 0-2) at 90 days were compared amongst the four groups. Results: Of the 486 patients enrolled (167 women, median age 74 years, median initial National Institutes of Health Stroke Scale score 13), reverse MRA-DWI mismatch was observed in 24 (5%). Of the clinical characteristics, cardioembolism was the only factor that was independently associated with RMM [odds ratio (OR) 5.49, 95% confidence interval (CI) 1.25-24.1]. Multivariable analyses revealed that patients with RMM more commonly had sICH than those with DWI-ASPECTS ≥ 7 irrespective of the presence (OR 5.44, 95% CI 1.13-26.1) or absence (13.1, 2.07-83.3) of MAO, and they had a more favorable functional outcome than those with DWI-ASPECTS < 7 plus MAO (7.45, 2.39-23.2). Conclusion: RMM was observed in 5% of patients treated with rt-PA and associated with cardioembolism. Patients with RMM may benefit from thrombolysis compared with those with EIC with MAO, although increment in the rate of sICH is a concern.
机译:背景与目的:反向磁共振血管造影和弥散加权成像(MRA-DWI)失配(RMM)的特征(在没有大动脉闭塞(MAO)的情况下被定义为大DWI病变)仍然未知,特别是在接受治疗的患者用静脉内重组组织纤溶酶原激活剂(rt-PA)。方法:包括脑中动脉区域中风的患者。早期缺血性改变(EIC)通过DWI的艾伯塔中风计划早期CT评分(DWI-ASPECTS)进行评估。根据MAO的存在和DWI-ASPECTS截止值<7将所有患者分为四组。 RMM定义为不具有MAO的DWI-ASPECTS <7。比较了四组患者在90天时的临床特征,症状性脑出血(sICH)和良好的功能结局(改良的Rankin量表评分0-2)。结果:在486名患者中(167名妇女,中位年龄74岁,美国国立卫生研究院中风初始评分中位数为13),在24名患者中观察到了反向MRA-DWI不匹配(5%)。在临床特征中,心脏栓塞是唯一与RMM相关的因素[几率(OR)5.49,95%置信区间(CI)1.25-24.1]。多变量分析显示,无论MAO是否存在(OR 5.44,95%CI 1.13-26.1)或不存在(13.1,2.07-83.3),RMM患者比DWI-ASPECTS≥7的患者更常见sICH。 DWI-ASPECTS <7加MAO的患者,其功能预后更好(7.45,2.39-23.2)。结论:rt-PA治疗并与心脏栓塞相关的患者中有5%发生RMM。与SIC合并MAO的患者相比,RMM患者可能受益于溶栓治疗,尽管sICH发生率增加是一个问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号